Supernus Pharmaceuticals, Inc. (SUPN)

48.33 -1.10 (-2.23%) USD  |  NASDAQ  |  May 18, 16:00
47.86 -0.47 (-0.97%) After-Hours: 20:00
More

Supernus Pharmaceuticals EBITDA Margin (TTM)

EBITDA Margin (TTM) Chart

View EBITDA Margin (TTM) for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Margin (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Margin (TTM) Range, Past 5 Years

View EBITDA Margin (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Margin (TTM) Benchmarks

View EBITDA Margin (TTM) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Johnson & Johnson Upgrade
Amphastar Pharmaceuticals, Inc. Upgrade
Assertio Holdings, Inc. Upgrade
Eli Lilly & Co. Upgrade